Global Retirement Partners, LLC Vericel Corp Transaction History

Global Retirement Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$41.71 - $52.9 $20,855 - $26,450	500 New	500 $22,000
Q3 2022 Nov 03, 2022	SELL	$22.62 - $32.54 $15,042 - $21,639	-665 Reduced 91.35%	63 $2,000
Q2 2022 Jul 15, 2022	BUY	$22.88 - $39.45 $915 - $1,578	40 Added 5.81%	728 $18,000
Q1 2022 Jul 14, 2022	BUY	$31.69 - $43.29 $21,802 - $29,783	688 New	688 $18,000
Q4 2021 Jan 21, 2022	SELL	$35.2 - $52.6 $2,147 - $3,208	-61 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$46.35 - $59.75 $2,827 - $3,644	61 New	61 $3,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.61B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.